- Home
- CYCN vs ADIL Comparison
CYCN vs ADIL Comparison
Compare CYCN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- ADIL
- Stock Information
- Founded
- CYCN 2018
- ADIL 2010
- Country
- CYCN United States
- ADIL United States
- Employees
- CYCN N/A
- ADIL N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- CYCN Health Care
- ADIL Health Care
- Exchange
- CYCN Nasdaq
- ADIL Nasdaq
- Market Cap
- CYCN 8.0M
- ADIL 7.6M
- IPO Year
- CYCN N/A
- ADIL 2018
- Fundamental
- Price
- CYCN $2.43
- ADIL $0.35
- Analyst Decision
- CYCN
- ADIL Strong Buy
- Analyst Count
- CYCN 0
- ADIL 1
- Target Price
- CYCN N/A
- ADIL $8.00
- AVG Volume (30 Days)
- CYCN 25.2K
- ADIL 553.7K
- Earning Date
- CYCN 11-13-2025
- ADIL 11-12-2025
- Dividend Yield
- CYCN N/A
- ADIL N/A
- EPS Growth
- CYCN N/A
- ADIL N/A
- EPS
- CYCN N/A
- ADIL N/A
- Revenue
- CYCN $2,174,000.00
- ADIL N/A
- Revenue This Year
- CYCN N/A
- ADIL N/A
- Revenue Next Year
- CYCN N/A
- ADIL N/A
- P/E Ratio
- CYCN N/A
- ADIL N/A
- Revenue Growth
- CYCN N/A
- ADIL N/A
- 52 Week Low
- CYCN $1.27
- ADIL $0.22
- 52 Week High
- CYCN $9.47
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- CYCN 47.88
- ADIL 38.03
- Support Level
- CYCN $2.13
- ADIL $0.36
- Resistance Level
- CYCN $2.59
- ADIL $0.38
- Average True Range (ATR)
- CYCN 0.20
- ADIL 0.02
- MACD
- CYCN 0.02
- ADIL 0.00
- Stochastic Oscillator
- CYCN 49.18
- ADIL 19.80
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.